Physician profile
Gregory William Basil
NPI 1245624386
$95,713.07
in general payments reported to CMS, 2019-2025
20 companies · $48K in 2025
The $48K reported for 2025 was more than what 95% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.21 · 2021: $635 · 2022: $12K · 2023: $17K · 2024: $18K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $65K · Travel and Lodging: $10K · Food and Beverage: $7,666 · Entertainment: $36.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $65,107.25 |
| Travel and Lodging | $10,489.78 |
| Food and Beverage | $7,666.43 |
| Entertainment | $36.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $41,455.54 | 2023-2025 | Xlif, Alif, Anthem |
| Medical Device Business Services, INC. | $17,619.43 | 2022-2024 | Teligen, Viper, Na |
| Elliquence, LLC | $9,054.60 | 2025 | |
| Amplify Surgical, INC. | $8,141.07 | 2025 | |
| Nuvasive, INC. | $7,240.58 | 2020-2023 | Xlif, Reline, Pcm |
| Depuy Synthes Sales INC. | $5,536.91 | 2022-2024 | Viper, Teligen, Chronos |
| Spineology INC. | $1,864.01 | 2022-2025 | Optimesh Expandable Interbody Fusion System |
| Alphatec Spine, INC | $1,296.50 | 2024-2025 | Other - Miscellaneous, Safeop, Biologics |
| Expanding Innovations, INC. | $1,199.90 | 2025 | X-Pac |
| Stryker Corporation | $611.92 | 2021-2024 | Serrato, N/A |
| Medtronic, INC. | $509.75 | 2022-2025 | |
| Carlsmed, INC. | $329.80 | 2022-2025 | Aprevo |
| 4web, INC. | $239.65 | 2023-2024 | Spine Truss System |
| Arthrex, INC. | $149.99 | 2025 | |
| Trackx Technology, INC. | $144.05 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cerapedics INC. | $122.11 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Theragen, INC. | $56.64 | 2022 | |
| Integrity Implants INC. Dba Accelus | $53.23 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $44.82 | 2022 | |
| Seaspine Orthopedics Corporation | $42.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$2,399.80 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Basil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.